QSC Research Grade · Shop at qscpeptide.com →

Cellular Senescence

Longevity science · How this pathway drives aging · How Midas addresses it

Cellular senescence is the state where cells permanently stop dividing but refuse to die. These "zombie cells" accumulate with age — by 60-70, senescent cells comprise 10-15% of cells in some tissues. They secrete a toxic cocktail called the Senescence-Associated Secretory Phenotype (SASP): IL-6, IL-8, TNF-α, MMPs, VEGF, and other factors that damage surrounding healthy tissue, recruit immune cells that cause collateral damage, and induce senescence in neighboring cells (paracrine senescence). Removing senescent cells in animal models has been shown to extend healthspan by 25-35%. FOXO4-DRI is the most targeted senolytic peptide — it specifically disrupts the FOXO4-p53 survival interaction that keeps senescent cells alive, triggering apoptosis exclusively in senescent cells while leaving healthy cells unaffected.

The Midas Approach

The Midas Longevity Protocol doesn't address cellular senescence in isolation — it targets this pathway alongside 9 other aging mechanisms simultaneously. This multi-pathway approach reflects the scientific consensus that aging is not a single process but a network of interconnected pathways (Lopez-Otin et al., Cell 2023, "Hallmarks of Aging").

Learn more: 12 Hallmarks of Aging & How Midas Maps to Each

Shop the Midas Longevity Protocol

12 compounds. 10 longevity pathways. 120 vials. ≥99% purity. Janoshik COA.

Buy at QSC →
The Protocol 12 Compounds Where to Buy FAQ Shop Now →

QSC Network

Shop QSC Compound Guides Ascension Stack Venus Protocol EU Warehouse

QSC Longevity Network

Research Use Only. All products are for laboratory research only. Not for human consumption. No medical claims. Supplied by QSC (qscpeptide.com). ≥99% HPLC purity, Janoshik COA.